Doctronic | Series BMar 2026$40M Series ASep 2025$20M | $60M |
| Co-investors: Faraz Fatemi (Lightspeed Venture Partners), Scott Belsky (capitalB), Fei-Fei Li (AI4ALL) |
Gyde | Series AJan 2026$60M | $60M |
| Co-investors: Ludwig Schulze (Alumni Ventures ), Vaibhav Domkundwar (Better Capital) |
Assort Health | Series BOct 2025$76M | $220M |
| Co-investors: Kristina Shen (Andreessen Horowitz), Joe Montana (Liquid 2 Ventures), Galym Imanbayev (Lightspeed Venture Partners), Matt Murphy (Menlo Ventures), JP (Jean-Paul) Sanday (Menlo Ventures), Bill Trenchard (First Round Capital), Matt Humphrey (Quiet Capital), Immad Akhund (Y Combinator) |
Thyme Care | Series DSep 2025$97M Series CJul 2024$55M Series BAug 2023$60M Series AOct 2021$22M | $230M |
| Co-investors: Vineeta Agarwala (Andreessen Horowitz), Kurt Sheline (Echo Health Ventures), Vivek Garipalli (Wormhole Capital), David Whelan (Town Hall Ventures), Vijay Patel (CVS Health Ventures), Faraz Rahman (CVS Health Ventures) |
Odyssey Therapeutics | Series DSep 2025$210M | $700M |
| Co-investors: Elena Viboch (General Catalyst), Jonathan MacQuitty (Lightspeed Venture Partners), Lorence Kim (Third Rock Ventures), Carl Gordon (OrbiMed Advisors), Jill carroll (SR One), Nan Li (6 Dimensions Capital), Ravi Mhatre (Anthropic) |
Tennr | Series CJun 2025$100M | $160M |
| Co-investors: Zeya Yang (Andreessen Horowitz), Jay Rughani (Andreessen Horowitz), Kristina Shen (Andreessen Horowitz), Galym Imanbayev (Lightspeed Venture Partners), Guru Chahal (Lightspeed Venture Partners), Somesh Dash (IVP), Joanne Chen (Foundation Capital), Jennifer Kaehms (Foundation Capital), Allison Pickens (Allison Pickens Ventures, formerly The New Normal Fund), Warrick Shanly (Soma Capital), Alex Kayyal (Salesforce Ventures) |
Neuralink | Series EMay 2025$650M | $1.2B |
| Co-investors: Fred Ehrsam (Paradigm), David Krane (GV (Google Ventures)), Andrew Reed (Sequoia Capital), Peter Thiel (Founders Fund), Jonathan MacQuitty (Lightspeed Venture Partners), Michael Mignano (Lightspeed Venture Partners), Shaun Maguire (Sequoia Capital), Krishna Yeshwant (GV (Google Ventures)), Blake Byers (GV (Google Ventures)), Ravi Mhatre (Anthropic), Robert Nelsen (ARCH Venture Partners), Bryan Rosenblatt (Craft Ventures), Ken Howery (Unknown Ventures), Bill Lee (Craft Ventures), Sam Altman, Shane Neman |
Antares Therapeutics | Series AMay 2025$180M | $180M |
| Co-investors: Jonathan MacQuitty (Lightspeed Venture Partners), Jean-François Formela (Atlas Venture), Ravi Mhatre (Anthropic) |